Multiple In Vitro and In Vivo Regulatory Effects of Budesonide in CD4+ T Lymphocyte Subpopulations of Allergic Asthmatics
Open Access
- 12 December 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (12) , e48816
Abstract
Increased activation and increased survival of T lymphocytes characterise bronchial asthma. In this study the effect of budesonide on T cell survival, on inducible co-stimulator T cells (ICOS), on Foxp3 and on IL-10 molecules in T lymphocyte sub-populations was assessed. Cell survival (by annexin V binding) and ICOS in total lymphocytes, in CD4+/CD25+ and in CD4+/CD25- and Foxp3 and IL-10 in CD4+/CD25+ and in CD4+/CD25-cells was evaluated, by cytofluorimetric analysis, in mild intermittent asthmatics (n = 19) and in controls (n = 15). Allergen induced T lymphocyte proliferation and the in vivo effects of budesonide in mild persistent asthmatics (n = 6) were also explored. Foxp3 was reduced in CD4+/CD25- and in CD4+/CD25+ cells and ICOS was reduced in CD4+/CD25+ cells but it was increased in CD4+CD25-in asthmatics when compared to controls. In asthmatics, in vitro, budesonide was able to: 1) increase annexin V binding and to reduce ICOS in total lymphocytes; 2) increase annexin V binding and Foxp3 and to reduce ICOS in CD4+/CD25- cells; 3) reduce annexin V binding and to increase IL-10 and ICOS in CD4+/CD25+ cells; 4) reduce cell allergen induced proliferation. In vivo, budesonide increased ICOS in CD4+/CD25+ while it increased Foxp3 and IL-10 in CD4+/CD25+ and in CD4+/CD25- cells. Budesonide modulates T cell survival, ICOS, Foxp3 and IL-10 molecules differently in T lymphocyte sub-populations. The findings provided shed light on new mechanisms by which corticosteroids, drugs widely used for the clinical management of bronchial asthma, control T lymphocyte activation.Keywords
This publication has 40 references indexed in Scilit:
- Cord Blood Derived CD4+CD25high T Cells Become Functional Regulatory T Cells upon Antigen EncounterPLOS ONE, 2012
- IL-35 production by inducible costimulator (ICOS)–positive regulatory T cells reverses established IL-17–dependent allergic airways diseaseJournal of Allergy and Clinical Immunology, 2012
- Alleviating allergic airway diseases by means of short-term administration of IL-2 and dexamethasoneJournal of Allergy and Clinical Immunology, 2011
- Targeting Toll-like receptors on dendritic cells modifies the TH2 response to peanut allergens in vitroJournal of Allergy and Clinical Immunology, 2010
- Conversion of Th2 memory cells into Foxp3 + regulatory T cells suppressing Th2-mediated allergic asthmaProceedings of the National Academy of Sciences, 2010
- Asthma: Clinical expression and molecular mechanismsJournal of Allergy and Clinical Immunology, 2010
- Naturally Occurring and Inducible T-Regulatory Cells Modulating Immune Response in Allergic AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2009
- In vivo switch to IL-10–secreting T regulatory cells in high dose allergen exposureJournal of Experimental Medicine, 2008
- Two Functional Subsets of FOXP3+ Regulatory T Cells in Human Thymus and PeripheryImmunity, 2008
- Immunosuppressive agents mediate reduced allostimulatory properties of myeloid-derived dendritic cells despite induction of divergent molecular phenotypesMolecular Immunology, 2005